Safety and effectiveness of natalizumab re-dosing and treatment in the STRATA study

被引：0
|
作者：
Polman, Chris H. [1 ]
Goodman, Andrew [2 ]
Kappos, Ludwig [3 ]
Lublin, Fred [4 ]
O'Connor, Paul [5 ]
Rudick, Richard [6 ]
Jurgensen, Stephanie [7 ]
Lucas, Nisha [7 ]
Abdul-Ahad, Ayad [7 ]
Panzara, Michael [7 ]
机构：
[1] VU Med Ctr, Amsterdam, Netherlands
[2] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Mt Sinai Sch Med, New York, NY USA
[5] St Michaels Hosp, Div Neurol, Toronto, ON M5B 1W8, Canada
[6] Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44195 USA
[7] Biogen Idec Inc, Cambridge, England
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [41] Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients
    Petrzalka, M.
    Meluzinova, E.
    Mojzisova, H.
    Libertinova, J.
    Rockova, P.
    Nema, E.
    Elisak, M.
    Marusic, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 79 - 83
  • [42] Impact of extended emergency department stay on antibiotic re-dosing delays and outcomes in sepsis
    Harpenau, Tara L.
    Bhatti, Samiyah N.
    Hoffman, Brian M.
    Kirsch, William B.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 32 - 37
  • [43] Do obstetric patients with major blood loss receive antibiotic re-dosing as routine practice?
    Butterworth, R.
    Roberts, K.
    Whitehouse, K.
    ANAESTHESIA, 2020, 75 : 64 - 64
  • [44] NATALIZUMAB EFFECTIVENESS AND SAFETY IN TOP UK PATIENTS
    Richard, Nicholas
    Karen, Rosales
    Stephanie, Licata
    Feisal, Syed Farooq Syed
    Caroline, Smethurst
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [45] Real world effectiveness of Natalizumab extended interval dosing in a French cohort
    Pelle, J.
    Briant, A.
    Lebrun-Frenay, C.
    Cohen, M.
    Mondot, L.
    De Seze, J.
    Bigaut, K.
    Collongues, N.
    Kremer, L.
    Ricard, D.
    Bompaire, F.
    Sallansonnet-Froment, M.
    Ohlmann, C.
    Ciron, J.
    Biotti, D.
    Pignolet, B.
    Parienti, J.
    Defer, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 207 - 207
  • [46] Improving compliance with intra-operative re-dosing of cefuroxime: a quality-improvement project
    Grant, O.
    O'Callaghan, L.
    Black, C.
    ANAESTHESIA, 2022, 77 : 18 - 18
  • [47] The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study
    Sousa, Lvia
    de Sa, Joao
    Jose Sa, Maria
    Cerqueira, Jose
    Martins-Silva, Ana
    REVISTA DE NEUROLOGIA, 2014, 59 (09) : 399 - 406
  • [48] Long-term effectiveness of extended interval dosing of natalizumab in multiple sclerosis
    Ryerson, L. Zhovtis
    Lee, S.
    Bacon, T.
    Toth, E.
    Chinea, R.
    Gragui, D.
    Kister, I.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 358 - 359
  • [49] Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
    Juliette Pelle
    Anais R. Briant
    Pierre Branger
    Nathalie Derache
    Charlotte Arnaud
    Christine Lebrun-Frenay
    Mikael Cohen
    Lydiane Mondot
    Jerome De Seze
    Kevin Bigaut
    Nicolas Collongues
    Laurent Kremer
    Damien Ricard
    Flavie Bompaire
    Charlotte Ohlmann
    Magali Sallansonnet-Froment
    Jonathan Ciron
    Damien Biotti
    Beatrice Pignolet
    Jean-Jacques Parienti
    Gilles Defer
    Neurology and Therapy, 2023, 12 : 529 - 542
  • [50] Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
    Pelle, Juliette
    Briant, Anais R.
    Branger, Pierre
    Derache, Nathalie
    Arnaud, Charlotte
    Lebrun-Frenay, Christine
    Cohen, Mikael
    Mondot, Lydiane
    De Seze, Jerome
    Bigaut, Kevin
    Collongues, Nicolas
    Kremer, Laurent
    Ricard, Damien
    Bompaire, Flavie
    Ohlmann, Charlotte
    Sallansonnet-Froment, Magali
    Ciron, Jonathan
    Biotti, Damien
    Pignolet, Beatrice
    Parienti, Jean-Jacques
    Defer, Gilles
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 529 - 542
12345